Blood donors' leftover immune cells reveal secrets of antibody affinity

March 9, 2018, American Society for Biochemistry and Molecular Biology

During some kinds of blood donations, you get most of your blood back. For example, platelet donation involves a procedure in which donor blood is filtered to harvest the platelets for medical use and the rest of the blood components are returned to the donor's body. The byproducts of this procedure - a fraction of immune cells - are typically discarded.

Researchers at Iowa State University, partnering with the LifeServe Blood Center, have used these leftover donor to gain crucial insights into how circulating in the differ from those typically studied in the lab. The results of this research are published in the March 9 issue of the Journal of Biological Chemistry.

Adam Barb, an associate professor of biochemistry at Iowa State, studies the receptor CD16a, which is found on the surface of natural killer cells and binds to the antibody immunoglobulin G (IgG). IgG is the most common antibody produced by the human body to coat the surfaces of pathogens or tumors and signal their destruction by natural killer cells. IgG is used as the basis of most antibody immunotherapies, for example against cancer.

How effectively natural killer cells can destroy their targets depends on how tightly the receptor binds to the antibody. Barb's team had previously found that the extent of this attraction, or affinity, depended on the types and amounts of carbohydrates attached to the antibody. In the new study, they set out to find how carbohydrate modifications of the receptor in humans affected the antibody-receptor binding affinity.

"We know that (receptors) can be expressed by the natural killer cell in thousands to millions of different forms," Barb said. "This is because the molecule is coated with complex carbohydrates, like a sugar coat, that can be highly variable."

Because NK cells are found at a low concentration in human blood, researchers who study these receptors typically insert the gene encoding the receptor into cells that can be grown in culture in the lab, an approach called recombinant expression. But it was not clear whether the conditions in cell culture would result in the same carbohydrate modifications to the receptor that occur in the human body.

"All of the work that had been done at that time...was studied with recombinant material, not from primary sources," Barb said. "People had assumed, with respect to this receptor, that the mammalian (cells) used for the recombinant expression would provide the correct types of carbohydrates."

In order to harvest the receptors from the source, Barb's team turned to a nearby blood bank that performed platelet apheresis, because they knew that a fraction of were discarded as part of the filtering procedure.

"When the donor is disconnected from the machine, they don't get those (lymphocytes) back, and that filter is usually just thrown away," Barb said. "So basically (they're) concentrating lymphocytes, including natural killer cells, which is exactly what we want, in these filters."

Barb's team obtained these filters from the blood bank and isolated the natural killer cells. They then examined the carbohydrate modifications of receptors from donors' natural killer cells and how these modifications affected binding to . They found that the carbohydrate modifications in the patients' receptors were much less elaborate than those from recombinant receptors, resulting in higher affinity.

"There was much less (carbohydrate) processing that the NK cells did in comparison to any of the forms that were expressed in these recombinant systems," Barb said. "And as a result of that, the affinity for antibody appears to be higher in natural killer cells than it would be in a receptor that was expressed from recombinant systems. Smaller carbohydrates appear to make for tighter binding interactions."The study was carried out on natural killer cell samples from donors that were of similar age, sex and blood type, raising the question of how the receptor's carbohydrate modifications may vary in natural populations.

"There appeared to be some degree of variability between donors," Barb said "(But) how does that change throughout the lifetime, how does that change in response to infection? All of those questions are absolutely things that we would very much like to investigate very specifically."

The results suggest that finding ways to influence the modifications of these could be a way to fine-tune antibody-receptor interactions in the context of antibody therapies.

Explore further: Researchers discover the unexpected role of platelets in immune response

More information: Kashyap R. Patel et al, Restricted processing of CD16a/Fc γ receptor IIIaN-glycans from primary human NK cells impacts structure and function, Journal of Biological Chemistry (2018). DOI: 10.1074/jbc.RA117.001207

Related Stories

Researchers discover the unexpected role of platelets in immune response

February 1, 2018
Platelets play a much more important role in our immune system than previously thought, according to a study published by researchers from Université Laval and Centre hospitalier universitaire (CHU) de Québec Research Centre. ...

Anti-viral rapid reaction force

December 27, 2016
After host cells have been attacked by a virus, they present parts of the pathogen on their surface. Thanks to these virus components, the killer cells patrolling in the body (CD8+ T lymphocytes) can recognise the infected ...

Crystal structure reveals how minor variations make receptor proteins activate or inhibit natural killer cells

August 27, 2014
Natural killer (NK) cells are white blood cells that can detect and destroy abnormal cells, including cancer cells or cells infected by viruses. A*STAR researchers have now resolved a longstanding puzzle concerning the receptor ...

Technique to generate antibodies for natural immune responses to cancer and leukemia

March 23, 2016
The artificial enhancement of the body's natural immune defenses is a potential weapon in the battle against diseases such as leukemia. A*STAR researchers are honing methods to boost the interactions between antibodies and ...

Immune cell 'switch' discovery raises hopes in cancer fight

February 26, 2016
The immune cells, called natural killer cells, hunt and destroy foreign cells in the body, including cancer cells that spread and form tumours.

Enhancing the effectiveness of a breast cancer treatment

February 13, 2012
Breast cancers expressing the protein HER2 have a particularly poor prognosis. Treatment with trastuzumab (Herceptin) benefits some patients with HER2-positive breast cancer, but it is not as effective as had been hoped. ...

Recommended for you

The 'greying' of T cells: Scientists pinpoint metabolic pathway behind age-related immunity loss

December 13, 2018
The elderly suffer more serious complications from infections and benefit less from vaccination than the general population. Scientists have long known that a weakened immune system is to blame but the exact mechanisms behind ...

Scientists create most accurate tool yet developed to predict asthma in young children

December 13, 2018
Scientists at Cincinnati Children's Hospital Medical Center have created and tested a decision tool that appears to be the most accurate, non-invasive method yet developed to predict asthma in young children.

New genetic study could lead to better treatment of severe asthma

December 12, 2018
The largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.

Researchers discover unique immune cell likely drives chronic inflammation

December 11, 2018
For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the general geriatric population ...

Macrophage cells key to helping heart repair—and potentially regenerate, new study finds

December 11, 2018
Scientists at the Peter Munk Cardiac Centre have identified the type of cell key to helping the heart repair and potentially regenerate following a heart attack.

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.